DNA polymerase ν (pol ν) inhibitors are a class of chemical compounds designed to specifically target and inhibit the enzymatic activity of DNA polymerase ν, an enzyme involved in DNA replication and repair processes. DNA pol ν is a member of the DNA polymerase family, which plays an essential role in the maintenance of genome stability by participating in DNA synthesis and various DNA repair mechanisms. Inhibitors of DNA pol ν work by binding to critical regions of the enzyme, such as the active catalytic site, thereby preventing it from catalyzing the addition of nucleotides during DNA synthesis. These inhibitors can function through different mechanisms, such as competitive inhibition, where the inhibitor directly competes with the natural nucleotide substrates for binding to the active site, or allosteric inhibition, where the inhibitor binds to a different site on the enzyme and induces conformational changes that impair its function. By blocking the activity of DNA pol ν, these inhibitors can interfere with the enzyme's ability to contribute to DNA synthesis and repair, providing a way to modulate its function in cellular processes.
The design and development of DNA pol ν inhibitors involve detailed structural analysis and computational modeling to understand the enzyme's architecture and identify potential binding sites for effective inhibition. Structural biology techniques, such as X-ray crystallography and cryo-electron microscopy (cryo-EM), are used to obtain high-resolution images of DNA pol ν, revealing the arrangement of its active site and other functional domains. This information is crucial for identifying specific regions that can be targeted by inhibitors. Computational tools, such as molecular docking and molecular dynamics simulations, help predict the interactions between potential inhibitors and DNA pol ν, allowing researchers to optimize the binding affinity and selectivity of these compounds. Chemical modifications are often introduced to improve key properties of the inhibitors, such as their stability, solubility, and specificity. The structure-activity relationship (SAR) studies are employed to understand how different chemical groups on the inhibitors influence their binding to DNA pol ν, guiding further optimization. These inhibitors can vary significantly in their chemical nature, ranging from small organic molecules that precisely target the catalytic pocket to larger, more complex structures that may bind to multiple regions of the enzyme. The successful development of DNA pol ν inhibitors requires a combination of structural insight, chemical synthesis, and computational refinement, providing valuable tools to study the role of DNA pol ν in DNA replication and repair pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $84.00 $306.00 $1104.00 | 30 | |
A tetracyclic diterpene that selectively inhibits DNA polymerases α, δ, and ε, but could also inhibit DNA pol ν by interfering with DNA synthesis. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
A topoisomerase II inhibitor that can lead to DNA damage and potentially impede DNA polymerases indirectly. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Targets DNA topoisomerase I and prevents DNA relegation, which can indirectly stress the DNA replication machinery. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interacts with DNA and inhibits DNA-dependent RNA polymerase, potentially affecting the availability of DNA templates for polymerases. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Forms cross-links in DNA, thereby inhibiting DNA synthesis and could indirectly affect DNA pol ν activity. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Inhibits ribonucleotide reductase, decreasing the pool of deoxyribonucleotides for DNA synthesis, which could impact DNA pol ν. | ||||||
1-β-D-Arabinofuranosylcytosine | 147-94-4 | sc-201628 sc-201628A sc-201628B sc-201628C sc-201628D | 1 g 5 g 25 g 100 g 250 g | $150.00 $263.00 $518.00 $731.00 $1461.00 | 1 | |
A nucleoside analog that gets incorporated into DNA and inhibits DNA polymerases. | ||||||
2′-Deoxy-2′,2′-difluorocytidine | 95058-81-4 | sc-275523 sc-275523A | 1 g 5 g | $56.00 $128.00 | ||
Another nucleoside analog that incorporates into DNA and inhibits DNA synthesis. | ||||||
β-Lapachone | 4707-32-8 | sc-200875 sc-200875A | 5 mg 25 mg | $112.00 $459.00 | 8 | |
Targets NQO1 and produces reactive oxygen species that can cause DNA damage, potentially affecting DNA pol ν indirectly. | ||||||
Fludarabine | 21679-14-1 | sc-204755 sc-204755A | 5 mg 25 mg | $58.00 $204.00 | 15 | |
A purine analog that inhibits DNA synthesis and can inhibit DNA polymerases after being incorporated into DNA. | ||||||